Back
Supernus Pharmaceuticals, Inc. Stock Price Chart
The Next Phase of AI Is Not About Chat
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Sell
41
SUPN
Supernus Pharmaceuticals, Inc.
Last Price:
$51.64
Seasonality Move:
4.69%
7 Day Trial
ALL ACCESS PASS
$
7
The Next AI Breakouts Won't Talk Like ChatGPT
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Supernus Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.18 | Buy |
| 20-day SMA: | 49.74 | Buy |
| 50-day SMA: | 48.85 | Buy |
| 200-day SMA: | 42.24 | Buy |
| 8-day EMA: | 38.68 | Buy |
| 20-day EMA: | 22.31 | Buy |
| 50-day EMA: | 10.52 | Buy |
| 200-day EMA: | 2.87 | Buy |
Supernus Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.09 | Buy |
| Relative Strength Index (14 RSI): | 62.97 | Buy |
| Chaikin Money Flow: | 586941 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.71 - 50.91) | Buy |
| Bollinger Bands (100): | (45.83 - 51.55) | Buy |
Supernus Pharmaceuticals, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals, Inc. Stock
Is Supernus Pharmaceuticals, Inc. Stock a Buy?
-
Supernus Pharmaceuticals, Inc. share price is 51.65 while SUPN 8-day simple moving average is 49.18, which is a Buy signal.
-
The stock price of SUPN is 51.65 while Supernus Pharmaceuticals, Inc. 20-day SMA is 49.74, which makes it a Buy.
-
Supernus Pharmaceuticals, Inc. 50-day simple moving average is 48.85 while SUPN share price is 51.65, making it a Buy technically.
-
SUPN stock price is 51.65 and Supernus Pharmaceuticals, Inc. 200-day simple moving average is 42.24, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
41
Supernus Pharmaceuticals, Inc. (SUPN)
is a Sell
Is Supernus Pharmaceuticals, Inc. a Buy or a Sell?
-
Supernus Pharmaceuticals, Inc. stock is rated a SellThe current Supernus Pharmaceuticals, Inc. [SUPN] share price is $51.65. The Score for SUPN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals, Inc. Stock Info
Market Cap:
3B
Price in USD:
51.65
Share Volume:
894K
Supernus Pharmaceuticals, Inc. 52-Week Range
52-Week High:
57.65
52-Week Low:
29.16
Sell
41
Supernus Pharmaceuticals, Inc. (SUPN)
is a Sell
Supernus Pharmaceuticals, Inc. Share Price Forecast
-
What is the Supernus Pharmaceuticals, Inc. stock price today?The Supernus Pharmaceuticals, Inc. stock price is 51.65 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals, Inc. is overvalued.
Is Supernus Pharmaceuticals, Inc. Stock a Buy?
-
Supernus Pharmaceuticals, Inc. share price is 51.65 while SUPN 8-day exponential moving average is 38.68, which is a Buy signal.
-
The stock price of SUPN is 51.65 while Supernus Pharmaceuticals, Inc. 20-day EMA is 22.31, which makes it a Buy.
-
Supernus Pharmaceuticals, Inc. 50-day exponential moving average is 10.52 while SUPN share price is 51.65, making it a Buy technically.
-
SUPN stock price is 51.65 and Supernus Pharmaceuticals, Inc. 200-day simple moving average is 2.87, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals, Inc.
Is Supernus Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.13 per share, and an increase next year of $1.53 per share.
Technical Analysis of Supernus Pharmaceuticals, Inc.
Should I short Supernus Pharmaceuticals, Inc. stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is 13.09, suggesting Supernus Pharmaceuticals, Inc. is a Buy
-
Supernus Pharmaceuticals, Inc. Relative Strength Index (RSI) is 62.97, which suggest Supernus Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Supernus Pharmaceuticals, Inc. is (48.71 - 50.91), which suggest Supernus Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Supernus Pharmaceuticals, Inc. is (45.83 - 51.55), which suggest Supernus Pharmaceuticals, Inc. is a Buy
* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.